Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 8/2001

01-10-2001 | Original Article

Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus

Authors: Masato Okamoto, Go Ohe, Tetsuya Oshikawa, Sachiko Furuichi, Hidetomo Nishikawa, Tomoyuki Tano, Sharif Ahmed, Hideo Yoshida, Yoichiro Moriya, Motoo Saito, Mitsunobu Sato

Published in: Cancer Immunology, Immunotherapy | Issue 8/2001

Login to get access
Metadata
Title
Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus
Authors
Masato Okamoto
Go Ohe
Tetsuya Oshikawa
Sachiko Furuichi
Hidetomo Nishikawa
Tomoyuki Tano
Sharif Ahmed
Hideo Yoshida
Yoichiro Moriya
Motoo Saito
Mitsunobu Sato
Publication date
01-10-2001
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 8/2001
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s002620100207

Other articles of this Issue 8/2001

Cancer Immunology, Immunotherapy 8/2001 Go to the issue

Original Article

A stable single-chain variable fragment expressing transfectoma demonstrates induction of idiotype-specific cytotoxic T-cells during early growth stages of a murine B-lymphoma

Review

Fever and cancer in perspective

Original Article

Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use

Original Article

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2

Original Article

Target cell induced activation of NK cells in vitro: cytokine production and enhancement of cytotoxic function
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits